Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Todd Neale

June 06, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

Shelley Wood

July 18, 2023

News Conference News ACC 2023

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

Michael O'Riordan

March 07, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Michael O'Riordan

November 22, 2022

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

MATRIX Score Predicts PCI Patients at High Risk for Transradial Failure

Michael O'Riordan

August 13, 2021

Advertisement

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

TAVI, SAVR Almost Equally Performed in California Patients Under 60

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

USPSTF: Screening Kids for Lipid Disorders Still Needs More Data

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Only Half of Revascularized PAD Patients Receive GDMT

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

What’s Going to Be Hot at ESC 2022?

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Good News and Bad for High-Intensity Statin Use in ASCVD

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

British Medical Groups Express Concern About Inclisiran Rollout

MATRIX Score Predicts PCI Patients at High Risk for Transradial Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content